Ruth Wittoek
UZ Gent · Ghent Universitary Hospital · UZ Ghent
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ruth Wittoek as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:59 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05570123 · Effect and Tolerance of Standardized Exclusive Dry Extracts of Curcuma Longa and of Boswellia Serrata Among People With Hand Joint Discomfort and DysfunctionTilman S.A. · completed · Hand Joint Discomfort, Hand Joint Dysfunction · principal investigator
- Ph2NCT04403698 · The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone TurnoverUniversity Hospital, Ghent · completed · Erosive Osteoarthritis · principal investigator
- Ph2NCT02771860 · RANKL-blockade for the Treatment of Erosive Osteoarthritis (OA) of Interphalangeal Finger JointsUniversity Hospital, Ghent · completed · Hand Osteoarthritis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:59 UTC. The ranking covers the 200 most relevant of 11 PubMed records, and a shared surname and initials can bring in a namesake. All 11 on PubMed
- Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification.Ann Rheum Dis · 2012163 citationsRCR 5.7
- 147 citationsRCR 7.0
- Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial.Ann Rheum Dis · 2018145 citationsRCR 6.4
- Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study.Arthritis Res Ther · 201977 citationsRCR 5.3
- Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial.Semin Arthritis Rheum · 202157 citationsRCR 4.6
- RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial.Nat Med · 202457 citationsRCR 10.9
- 3 T DCE-MRI assessment of synovitis of the interphalangeal joints in patients with erosive osteoarthritis for treatment response monitoring.Skeletal Radiol · 201316 citationsRCR 0.7
- Etanercept therapy leads to reductions in matrix metalloproteinase-3 in patients with erosive hand osteoarthritis.Scand J Rheumatol · 202012 citationsRCR 0.7
- Neuropathic-like pain in knee osteoarthritis: exploring differences in knee loading and inflammation. A cross-sectional study.Eur J Phys Rehabil Med · 20248 citationsRCR 2.2
- Topographical analysis of structural lesions between dominant and non-dominant hands in erosive osteoarthritis.Rheumatol Int · 20212 citationsRCR 0.2